AU2001236606A1 - 3,4-dihydro-2h-benzo(1,4)oxazine inhibitors of factor xa - Google Patents
3,4-dihydro-2h-benzo(1,4)oxazine inhibitors of factor xaInfo
- Publication number
- AU2001236606A1 AU2001236606A1 AU2001236606A AU3660601A AU2001236606A1 AU 2001236606 A1 AU2001236606 A1 AU 2001236606A1 AU 2001236606 A AU2001236606 A AU 2001236606A AU 3660601 A AU3660601 A AU 3660601A AU 2001236606 A1 AU2001236606 A1 AU 2001236606A1
- Authority
- AU
- Australia
- Prior art keywords
- oxazine
- benzo
- dihydro
- inhibitors
- factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17939100P | 2000-02-01 | 2000-02-01 | |
| US60179391 | 2000-02-01 | ||
| US19173400P | 2000-03-04 | 2000-03-04 | |
| US60191734 | 2000-03-04 | ||
| PCT/US2001/003226 WO2001057003A1 (en) | 2000-02-01 | 2001-02-01 | 3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE INHIBITORS OF FACTOR Xa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001236606A1 true AU2001236606A1 (en) | 2001-08-14 |
Family
ID=26875282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001236606A Abandoned AU2001236606A1 (en) | 2000-02-01 | 2001-02-01 | 3,4-dihydro-2h-benzo(1,4)oxazine inhibitors of factor xa |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20020013314A1 (en) |
| EP (1) | EP1255743A1 (en) |
| AU (1) | AU2001236606A1 (en) |
| WO (1) | WO2001057003A1 (en) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6670364B2 (en) | 2001-01-31 | 2003-12-30 | Telik, Inc. | Antagonists of MCP-1 function and methods of use thereof |
| US6962926B2 (en) | 2001-01-31 | 2005-11-08 | Telik, Inc. | Antagonist of MCP-1 function, and compositions and methods of use thereof |
| TWI245761B (en) | 2001-03-01 | 2005-12-21 | Telik Inc | Antagonists of MCP-1 function and methods of use thereof |
| US6677365B2 (en) | 2001-04-03 | 2004-01-13 | Telik, Inc. | Antagonists of MCP-1 function and methods of use thereof |
| WO2002085868A1 (en) * | 2001-04-23 | 2002-10-31 | Astrazeneca Ab | Benzoxazinone derivatives for use in the treatment of angiogenesis |
| WO2003095434A1 (en) | 2002-05-13 | 2003-11-20 | F. Hoffmann-La Roche Ag | Benzoxazine derivatives as 5-ht6 modulators and uses thereof |
| AU2003248549B2 (en) | 2002-05-24 | 2010-04-08 | Millennium Pharmaceuticals, Inc. | CCR9 inhibitors and methods of use thereof |
| PL377770A1 (en) | 2002-11-08 | 2006-02-20 | F. Hoffmann-La Roche Ag | Substituted benzoxazinones and uses thereof |
| US7420055B2 (en) | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
| US7227035B2 (en) * | 2002-11-18 | 2007-06-05 | Chemocentryx | Bis-aryl sulfonamides |
| JP4611746B2 (en) | 2002-11-18 | 2011-01-12 | ケモセントリックス， インコーポレイテッド | Arylsulfonamide |
| US7741519B2 (en) | 2007-04-23 | 2010-06-22 | Chemocentryx, Inc. | Bis-aryl sulfonamides |
| US20070021466A1 (en) * | 2002-11-18 | 2007-01-25 | Solomon Ungashe | CCR2 inhibitors and methods of use thereof |
| DK1569912T3 (en) | 2002-12-03 | 2015-06-29 | Pharmacyclics Inc | 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors. |
| TWI289141B (en) | 2003-03-11 | 2007-11-01 | Hoffmann La Roche F. Ag. | Quinolinone derivatives and uses thereof |
| SI21658A (en) * | 2003-11-28 | 2005-06-30 | Univerza V Ljubljani | Antithrombotic active ingredients with dual mechanism of action basedon 3,4-dihydro-2h-1,4-benzoxazine skeleton |
| CN100532369C (en) | 2003-12-09 | 2009-08-26 | 弗·哈夫曼-拉罗切有限公司 | Benzoxazine derivatives and uses thereof |
| US7378415B2 (en) | 2004-09-30 | 2008-05-27 | Roche Palo Alto Llc | Benzoxazine and quinoxaline derivatives and uses thereof |
| JP5099814B2 (en) * | 2006-02-02 | 2012-12-19 | 田辺三菱製薬株式会社 | Nitrogen-containing heterobicyclic compounds |
| TWI385161B (en) | 2006-02-02 | 2013-02-11 | Mitsubishi Tanabe Pharma Corp | Nitrogen-containing heterobicyclic compounds |
| JP2009536953A (en) | 2006-05-11 | 2009-10-22 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 1,2,3,4-Tetrahydro-quinoline derivatives as CETP inhibitors |
| CA2651817A1 (en) * | 2006-05-11 | 2007-11-22 | Janssen Pharmaceutica N.V. | 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as cetp inhibitors |
| JP5173653B2 (en) * | 2007-08-01 | 2013-04-03 | 田辺三菱製薬株式会社 | Pharmaceutical composition |
| US20090253693A1 (en) * | 2008-04-07 | 2009-10-08 | Dmitry Koltun | 2H-BENZO[b][1,4]OXAZIN-3(4H)-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
| TW201100398A (en) | 2009-03-31 | 2011-01-01 | Arqule Inc | Substituted indolo-pyridinone compounds |
| JO3398B1 (en) | 2011-12-22 | 2019-10-20 | Novartis Ag | 2,3-Dihydro-benzo[1,4]oxazine derivatives and related compounds as phosphoinositide-3 kinase (PI3K) inhibitors for the treatment of e.g. rheumatoid arthritis |
| WO2017040963A1 (en) | 2015-09-03 | 2017-03-09 | Forma Therapeutics, Inc. | [6,6] fused bicyclic hdac8 inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999037643A1 (en) * | 1998-01-26 | 1999-07-29 | Yamanouchi Pharmaceutical Co., Ltd. | Novel benzene-fused heterocyclic derivatives or salts thereof |
| PL343317A1 (en) * | 1998-03-31 | 2001-08-13 | Warner Lambert Co | Benzoxazinones/benzothiazinones as serine protease inhibitors |
| CA2380727A1 (en) * | 1999-07-16 | 2001-01-25 | Bristol-Myers Squibb Pharma Company | Nitrogen containing heterobicycles as factor xa inhibitors |
| US6534535B1 (en) * | 1999-08-12 | 2003-03-18 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
-
2001
- 2001-02-01 AU AU2001236606A patent/AU2001236606A1/en not_active Abandoned
- 2001-02-01 EP EP01908771A patent/EP1255743A1/en not_active Withdrawn
- 2001-02-01 US US09/773,373 patent/US20020013314A1/en not_active Abandoned
- 2001-02-01 WO PCT/US2001/003226 patent/WO2001057003A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001057003A1 (en) | 2001-08-09 |
| EP1255743A1 (en) | 2002-11-13 |
| US20020013314A1 (en) | 2002-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001236606A1 (en) | 3,4-dihydro-2h-benzo(1,4)oxazine inhibitors of factor xa | |
| AU2001273040A1 (en) | Factor xa inhibitors | |
| AU2002215218A1 (en) | Isoxazole derivatives | |
| AU2002351179A1 (en) | Glycinamides as factor xa inhibitors | |
| AU2001262475A1 (en) | Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses | |
| AU7490900A (en) | Chemical compounds and compositions and their use as cathepsin s inhibitors | |
| AU2002359200A1 (en) | New composition | |
| AU2001230026A1 (en) | 2,4-diaminothiazole derivatives | |
| AU2494300A (en) | 3,4-dihydro-2h-benzo(1,4)oxazine derivatives | |
| AU2002216649A1 (en) | Benzoxazole lpaat- beta inhibitors and uses thereof | |
| AU2001288824A1 (en) | Self-actuating, traction-drive speed changer | |
| AU2001257038A1 (en) | Electro-desorption compressor | |
| AU2001241098A1 (en) | Composition | |
| AU2001234313A1 (en) | Novel phenylheteroalkylamine derivatives | |
| AU2001240605A1 (en) | Endoparasiticidal agents | |
| AU2002222933A1 (en) | Inhibitors of factor xa | |
| AU2002348501A1 (en) | Factor xa inhibitor | |
| AU2001275201A1 (en) | Acne-treating composition | |
| AU2001263083A1 (en) | Biologically active 4h-benzo(1,4)oxazin-3-ones | |
| AU2002251688A1 (en) | Machining | |
| AU2001232089A1 (en) | Compound, composition and use | |
| AU2002214975A1 (en) | Novel 1,4-diamino-2-alkenyl-benzene derivatives and colorants containing said compounds | |
| AU7846700A (en) | Oxazoline or oxazine coating compositions | |
| AU2002245127A1 (en) | Oxazolidinone photoaffinity probes, uses and compounds | |
| AU2002219846A1 (en) | Novel use |